Financhill
Back

CureVac NV 10K Form

Sell
47

CVAC
CureVac NV

Last Price:
2.71
Seasonality Move:
14.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CVAC News And Ratings

See the #1 stock for the next 7 days that we like better than CVAC

CVAC Financial Statistics

Sales & Book Value

Annual Sales: $58.2M
Cash Flow: $-103.05M
Price / Cash Flow: 0
Annual Sales: $1.80
Price / Book: 1.53

Profitability

EPS (TTM): -1.34080
Net Income (TTM): $-301.07M
Gross Margin: $-76.44M
Return on Equity: -53.75%
Return on Assets: -36.87%

CureVac NV Earnings Forecast

Key CureVac NV Financial Ratios

  • The Gross Profit Margin over the past 6 years for CVAC is -131.34%.
  • The Selling, General & Administrative Expenses for CVAC have been equal to 142.18% of Gross Profit Margin.
  • The Research & Development expenses have been 215.27% of Revenue.
  • The Interest Expense is -0.96% of Operating Income.
  • The Net Earning history of CVAC is -483.96% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

CureVac NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CVAC
Website: curevac.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.29
Quick Ratio: 2.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CVAC Technical Analysis vs Fundamental Analysis

Sell
47
CureVac NV (CVAC) is a Sell

Is CureVac NV a Buy or a Sell?

  • CureVac NV stock is rated a Sell
    The current CureVac NV [CVAC] share price is $2.76. The Score for CVAC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.